About 75 percent of patients taking oxycodone controlled-release for chronic pain report suffering from side effects, according to Pharmacy News. A recent study found while the oxycodone ...
A post-hoc analysis of a Phase 3 safety study demonstrated that tapentadol tablets were associated with a lower incidence of nausea, vomiting and constipation when compared to oxycodone immediate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results